A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

Hepatology

Volumn 28, Issue 3, 1998, Pages 751-755

  Manghisi, Giuseppe ^a   Elba, Silvana ^a   Mossa, Ascanio ^a   Giorgio, Antonio ^b   Aloisio, Vincenza ^b   Perrotta, Anna ^b   Tardio, Berardino ^c   Del Naja, Carlo ^c   Caturelli, Eugenio ^c   Calandra, Maria ^d   Castellano, Luigi ^d   De Sio, Ilario ^d   Capuano, Gaetano ^e   Pomponi, Domenico ^e   Castiglione, Fabiana ^f   Cocchia, Pasqualina ^f   Farinati, Fabio ^g   Rinaldi, Michela ^g   Adinolfi, Luigi Elio ^d   Ragone, Enrico ^d   Felder, Martina ^h   Zancanella, Laura ^h   Pasquale, Giuseppe ^d   Stanzione, Maria ^d   Marone, Giampiero ⁱ   D’Angelo, Valentina ⁱ   Gaeta, Giovanni Battista ^d   Giolitto, Giancarlo ^d   Lamborgese, Bruno ^j   Manzione, Luigi ^j   Russo, Michele ^d   Colurcio, Raffaele ^d   Veltri, Enzo ^k   Izzo, Francesco ^l   Budillon, Gabriele ^e   Caporaso, Nicola ^d   Blanco, Camillo Del Vecchio ^d   Galanti, Bruno ^d   Giusti, Giuseppe ^d   Mazzacca, Gabriele ^f   Monfardini, Silvio ^m   Piccinino, Felice ^d   Ruggiero, Giuseppe ^d   Gallo, Ciro ^d,n   Perrone, Francesco ^m,n   De Placido, Sabino ^e,n   Canzanella, Giuliana ^m   Daniele, Bruno ^m   Pignata, Sandro ^m   more..

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e Cattedra di Oncologia Medica   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^h Ospedale di Bolzano   (Italy)

ⁱ Divisione di Cardiologia UTIC   (Italy)

^j SAN CARLO HOSPITAL   (Italy)

^k SANTA MARIA GORETTI HOSPITAL   (Italy)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m Department of Epidemiology   (Italy)

ⁿ CNR   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; DISEASE MARKER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0031782818     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.510280322     Document Type: Article

References (28)

1. Okuda K, Ohtsuki T, Obata H, Tominatsu M, Okazaki N, Hasegawa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918-928.
2. Pugh RNH, Murray-Lyon IM, Dawson J-L, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
3. Kaplan EL, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
4. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966;50:163-170.
5. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34:187-220.
6. Dixon WJ. BMDP Statistical Software, Los Angeles, CA: University of California Press, 1992.
7. Nomura F, Ohnishi K, Honda M, Satomura Y, Nakai T, Okuda K. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 1994;70:690-693.
8. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. HEPATOLOGY 1994;19:1115-1123.
9. Lencioni R, Bartolozzi C, Caramella D, Paolicchi A, Carrai M, Maltinti G, Capria A, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Cancer 1995;76:1737-1746.
10. Yamashita Y, Takahashi M, Koga Y, Saito R, Nanakawa S, Hatanaka Y, Sato N, et al. Prognostic factor in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 1991;67:385-391.
11. Taniguchi K, Nakata K, Kato Y, Sato Y, Hamasaki K, Tsuruta S, Nagataki S. Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Cancer 1994;73:1341-1345.
12. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401.
13. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-2222.
14. Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985;89:279-285.
15. Tublin ME, Dodd GD III, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. Am J Roentgenol 1997;168:719-723.
16. Dodd GD III, Memel DS, Baron RL, Eichner L, Santiguida LA. Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? Am J Roentgenol 1995;165:573-577.
17. Cedrone A, Rapaccini GL, Pompili M, Aliotta A, Trombino C, De Luca F, Caturelli E, et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver 1996;16:94-98.
18. De Sio I, Castellano L, Calandra M, Romano M, Persico M, Del Vecchio Blanco C. Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. J Gastroenterol Hepatol 1995;10:662-665.
19. Chlebowski RT, Tong M,Weissman J, Block JB, Ramming KP,Weiner JM, Bateman JR, et al. Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer 1984;53:2701-2706.
20. Attali P, Prod’Homme S, Pelletier G, Papoz L, Ink O, Buffet C, Etienne JP. Prognostic factor in patients with hepatocellular carcinoma. Cancer 1987;59:2108-2111.
21. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28-35.
22. Akashi Y, Koreeda C, Enomoto S, Uchiyama S, Mizuno T, Shiozaki Y, Sameshima Y, et al. Prognosis of unresectable hepatocellular carcinoma:an evaluation based on multivariate analysis of 90 cases. HEPATOLOGY 1991;14:262-268.
23. Shijo H, Okazaki M, Higashihara H, Koganemaru F, Okumura M. Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization. Am J Gastroenterol 1992;87:1154-1159.
24. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognostic of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Cancer 1989;64:1700-1707.
25. Trevisani F, Caraceni P, Bernardi M, D’Intino PE, Arienti V, Amorati P, Stefanini GF, et al. Gross pathologic types of hepatocellular carcinoma in Italian patients. Cancer 1993;72:1557-1563.
26. Trevisani F, D’Intino PE, Grazi GL, Caraceni P, Gasbarrini A, Colantoni A, Stefanini GF, et al. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 1996;77:2223-2232.
27. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. Cancer 1984;54:1461-1465.
28. Yamasaki T, Kurokawa F, Kato A, Irie K, Yutoku K, Terai S, Matsuzaki Y, et al. Clinicopathologic features of early hepatocellular carcinoma. Hepatogastroenterology 1996;43:926-931.